EDGAR Filing Documents for 0000950135-96-000945

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

SEC Accession No. 0000950135-96-000945

Filing Date

1996-02-12

Accepted

1996-02-12 00:00:00

Documents

Period of Report

1995-08-31

SROs

NASD

Document Format Files

Seq	Description	Document	Type	Size
1	GENOME THERAPEUTICS AMENDMENT NO. 3		10-K/A	170317
2	AGREEMENT		EX-10.28	93153
3	U.S. GOV'T GRANT FROM NATIONAL INST. OF HEALTH		EX-10.31	26894
4	U.S. GOV'T GRANT FROM NAT'L HUMAN GENOME RESEARCH		EX-10.32	50773
5	U.S. GOV'T GRANT FROM NAT'L CENTER FOR HUMAN		EX-10.33	69242
6	U.S. GOV'T GRANT CONTRACT FROM NAT'L INST. NUERO.		EX-10.34	140640
7	COOPERATIVE AGREEMENT		EX-10.35	119144
8	CREDIT AGRREMENT		EX-10.36	110626
9	CONSENT OF ARTHUR ANDERSEN LLP		EX-23	862
	Complete submission text file	0000950135-96-000945.txt		784097

Mailing Address 100 BEAVER STREET WALTHAM MA 02154

Business Address 1OO BEAVER ST WALTHAM MA 02154 6178935007

GENOME THERAPEUTICS CORP (Filer) CIK: 0000356830 (see all company filings)